Kiromic Biopharma Outlines Vision in Stakeholder Meetings
PremiumCompany AnnouncementsKiromic Biopharma Outlines Vision in Stakeholder Meetings
7M ago
Kiromic Biopharma Strikes $2M Convertible Debt Deal for Growth
Premium
Company Announcements
Kiromic Biopharma Strikes $2M Convertible Debt Deal for Growth
9M ago
option delistings on September 25th
Premium
The Fly
option delistings on September 25th
1y ago
Kiromic BioPharma submits IND for Deltacel trial for NSLC treatment
PremiumThe FlyKiromic BioPharma submits IND for Deltacel trial for NSLC treatment
2y ago
Kiromic BioPharma announces 1-for-30 reverse stock split
Premium
The Fly
Kiromic BioPharma announces 1-for-30 reverse stock split
2y ago
Kiromic reports favorable Deltacel preclinical pharmacology results
Premium
The Fly
Kiromic reports favorable Deltacel preclinical pharmacology results
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100